Source: PR Newswire

Press Release: BioDirection : BioDirection, Inc. Holds Pre-Submission Meeting with FDA

BOSTON, Nov. 29, 2016 /PRNewswire/ -- BioDirection, a privately held medical device company developing novel and rapid point-of-care products for the objective detection of concussion and other traumatic brain injury (TBI), announced today that the company has successfully completed a...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Sharad H. Joshi's photo - President & CEO of BioDirection

President & CEO

Sharad H. Joshi

CEO Approval Rating

90/100

Read more